News
The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.
2d
FOX 11 Los Angeles on MSNCalifornia now selling generic Narcan for $24California is ramping up efforts to combat the opioid epidemic by rolling out online sales of a drug that can reverse ...
Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...
Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...
They had given patients oral supplements of vitamin D to reduce nasal inflammation and reverse the loss of the sense of smell the inflammation often causes. "It helped zero of 28 people," she said.
From 3,500 puff vapes to super-strength nicotine pouches, why are young people willing to risk their health for a stronger hit? Ella Glover reports Sign up for the best picks from our travel ...
Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...
Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...
For patients with seizure episodes reaching t1 (671 events of t1 SE in 97 patients), diazepam nasal spray provided timely control of SE episodes. Overall, safety was generally consistent with the ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Riot police officers use pepper spray to clear a ...
Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYSTâ„¢ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results